Burcon NutraScience Corporation
BU.TO · TSX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.57 | -0.21 | -0.00 | 2.53 |
| FCF Yield | -8.28% | -5.55% | -5.86% | -0.32% |
| EV / EBITDA | -24.72 | -28.61 | -17.97 | -269.68 |
| Quality | ||||
| ROIC | -12.61% | -9.57% | -6.61% | -23.21% |
| Gross Margin | -680.23% | -419.21% | -1,283.50% | -367.34% |
| Cash Conversion Ratio | 0.55 | 0.77 | 0.45 | 0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.49% | 21.22% | 1.58% | -8.44% |
| Free Cash Flow Growth | 11.45% | -155.46% | 24.78% | -20.39% |
| Safety | ||||
| Net Debt / EBITDA | -10.27 | -7.49 | -7.99 | -4.19 |
| Interest Coverage | -3.58 | -3.15 | -5.49 | -189.18 |
| Efficiency | ||||
| Inventory Turnover | 5.94 | 4.74 | 2.95 | 1.22 |
| Cash Conversion Cycle | 72.98 | 98.31 | 67.85 | -87.25 |